Wednesday, October 9, 2024
Home Diseases conditions and syndromes Higher burden of comorbidity linked to worse clinical outcomes in multiple sclerosis

Higher burden of comorbidity linked to worse clinical outcomes in multiple sclerosis

by Medical Xpress
0 comment



For people with multiple sclerosis (MS), a higher burden of comorbidity is associated with worse clinical outcomes, according to a study published online Sept. 18 in JAMA Neurology to coincide with the annual meeting of the European Committee for Treatment and Research in Multiple Sclerosis, held from Sept. 18 to 20 in Copenhagen, Denmark.

Amber Salter, Ph.D., from UT Southwestern Medical Center in Dallas, and colleagues examined the association of comorbidities with disease activity in clinical trials of disease-modifying therapies in populations with MS in a two-stage meta-analytic approach. The included individual participant data for 16,794 participants with MS from 17 phase 3 clinical trials of MS disease-modifying therapies.

The researchers found that 61.0% of the pooled trials had evidence of (EDA) during the two-year follow-up period. After adjustment for multiple factors, compared with no comorbidity, the presence of three or more comorbidities was associated with an increased risk for EDA (adjusted hazard ratio, 1.14).

The risk for EDA was also increased with the presence of two or more versus no cardiometabolic conditions (adjusted hazard ratio, 1.21). Increased hazard of EDA was seen in association with one psychiatric disorder (adjusted hazard ratio, 1.07).

“As these findings are coherent with using different study designs and data sources, evidence suggests that clinicians need to routinely address comorbidity in people with MS,” the authors write.

Several authors disclosed ties to the biopharmaceutical industry; the study was based on research using data from pharmaceutical companies.

More information:
Amber Salter et al, Comorbidity and Disease Activity in Multiple Sclerosis, JAMA Neurology (2024). DOI: 10.1001/jamaneurol.2024.2920

© 2024 HealthDay. All rights reserved.

Citation:
Higher burden of comorbidity linked to worse clinical outcomes in multiple sclerosis (2024, September 23)
retrieved 23 September 2024
from https://medicalxpress.com/news/2024-09-higher-burden-comorbidity-linked-worse.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

You may also like

Leave a Comment

Edtior's Picks

Latest Articles

All Rights reserved, site designed by Yellohost.co.za